Semagacestat – Gamma Secretase Inhibitor for Alzheimer's Disease (AD)
Key Data:
Drug (Brand/Generic)
Semagacestat (LY-450139)
Company/Licensee
Eli Lilly
Therapy Class
Gamma secretase inhibitor
Product Description
Anti-amyloid therapy
Current Indication
Alzheimer's disease
Market Sector
CNS
Development Status
Second Phase III study
